WDFY3 Gene

WDFY3 — WD Repeat and FYVE Domain Containing 3

Introduction

Wdfy3 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

WDFY3 (also known as Alfy — [Autophagy](/entities/autophagy) FYVE protein) is a critical selective autophagy receptor that plays essential roles in protein quality control and neuronal health. It is encoded by the WDFY3 gene located on chromosome 4q21.23 and has emerged as an important player in neurodegenerative diseases, particularly Alzheimer's disease, due to its role in清除错误折叠的蛋白质聚集体^[1].

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">WDFY3 (Alfy)</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>WDFY3</td></tr>
<tr><td><strong>Full Name</strong></td><td>WD repeat and FYVE domain containing 3</td></tr>
<tr><td><strong>Chromosome</strong></td><td>4q21.23</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[23078](https://www.ncbi.nlm.nih.gov/gene/23078)</td></tr>
<tr><td><strong>OMIM</strong></td><td>617010</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000155636</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q9Y4E5](https://www.uniprot.org/uniprot/Q9Y4E5)</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>[Alzheimer's Disease](/diseases/alzheimers), [ALS](/diseases/als), Autophagy Defects, Intellectual Disability</td></tr>
</table>
</div>

...

WDFY3 — WD Repeat and FYVE Domain Containing 3

Introduction

Wdfy3 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

WDFY3 (also known as Alfy — [Autophagy](/entities/autophagy) FYVE protein) is a critical selective autophagy receptor that plays essential roles in protein quality control and neuronal health. It is encoded by the WDFY3 gene located on chromosome 4q21.23 and has emerged as an important player in neurodegenerative diseases, particularly Alzheimer's disease, due to its role in清除错误折叠的蛋白质聚集体^[1].

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">WDFY3 (Alfy)</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>WDFY3</td></tr>
<tr><td><strong>Full Name</strong></td><td>WD repeat and FYVE domain containing 3</td></tr>
<tr><td><strong>Chromosome</strong></td><td>4q21.23</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[23078](https://www.ncbi.nlm.nih.gov/gene/23078)</td></tr>
<tr><td><strong>OMIM</strong></td><td>617010</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000155636</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q9Y4E5](https://www.uniprot.org/uniprot/Q9Y4E5)</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>[Alzheimer's Disease](/diseases/alzheimers), [ALS](/diseases/als), Autophagy Defects, Intellectual Disability</td></tr>
</table>
</div>

Overview

WDFY3 (WD Repeat and FYVE Domain Containing 3), also known as Alfy (Autophagy-Linked FYVE protein), is a gene on chromosome 4q21.23 encoding a critical selective autophagy receptor that plays essential roles in protein quality control and neuronal health. WDFY3 has emerged as an important player in neurodegenerative diseases, particularly Alzheimer's disease and ALS, due to its role in清除错误折叠的蛋白质聚集体. The protein serves as a molecular scaffold, bridging ubiquitinated protein aggregates to the core autophagy machinery through its WD40 repeats, FYVE domain, and LC3-interacting region.

Structure

WDFY3 is a large protein (~3,528 amino acids) characterized by multiple functional domains:

• WD40 Repeats (N-terminal): Form a beta-propeller structure involved in protein-protein interactions
• FYVE Domain (C-terminal): Binds to phosphatidylinositol 3-phosphate (PI3P) on endosomal membranes, targeting the protein to autophagosomes
• Phosphoinositide-Binding Region: Mediates membrane association
• LC3-Interacting Region (LIR): Directly interacts with LC3/GABARAP proteins on the autophagosome membrane^[2]

This multi-domain architecture enables WDFY3 to serve as a molecular scaffold, bridging ubiquitinated protein aggregates to the core autophagy machinery.

Function in Selective Autophagy

WDFY3 functions as a selective autophagy receptor with several critical functions:

Aggregate Recognition

WDFY3 specifically recognizes and binds to:

• Ubiquitinated protein aggregates: The protein contains ubiquitin-binding domains that recognize ubiquitinated misfolded proteins^[3]
• Aggresomes: Large cytoplasmic protein aggregates formed under proteotoxic stress
• Damaged organelles: Including mitochondria (mitophagy) and endoplasmic reticulum (reticulophagy)

Autophagy Mediation

WDFY3 facilitates selective autophagy through:

Aggregate targeting: Directs protein aggregates to the growing autophagosome by binding to both ubiquitinated substrates and LC3 on the phagophore membrane^[4]

Phagophore recruitment: Uses its FYVE domain to localize to PI3P-rich autophagosome formation sites

Autophagy gene regulation: Also functions as a transcriptional co-regulator, controlling expression of autophagy genes

Neurodevelopmental Role

Beyond autophagy, WDFY3 plays important roles in brain development:

• Regulates neuronal migration during cortical development
• Controls dendritic arborization and synapse formation
• Mutations cause autosomal dominant intellectual disability with macrocephaly^[5]

Role in Neurodegenerative Diseases

Alzheimer's Disease

WDFY3 has emerged as a significant factor in AD pathogenesis:

• Genetic association: Rare variants in WDFY3 have been linked to increased risk for late-onset Alzheimer's disease through genome-wide association studies^[6]
• Amyloid-beta clearance: WDFY3-mediated selective autophagy helps clear [amyloid-beta](/proteins/amyloid-beta) plaques; reduced WDFY3 function leads to amyloid accumulation in cellular and animal models^[7]
• [Tau](/proteins/tau) pathology: WDFY3 helps target hyperphosphorylated tau for autophagic degradation; dysfunction contributes to tau aggregation and neurofibrillary tangle formation
• Autophagy-lysosomal dysfunction: WDFY3 deficiency exacerbates the autophagy defects observed in AD brains, creating a vicious cycle of protein aggregate accumulation

Amyotrophic Lateral Sclerosis (ALS)

• Protein aggregate clearance: WDFY3 helps clear [TDP-43](/proteins/tdp-43) and SOD1 aggregates characteristic of ALS
• Motor neuron vulnerability: Reduced WDFY3 function may contribute to the accumulation of toxic protein aggregates in motor [neurons](/entities/neurons)
• Genetic links: WDFY3 variants have been identified in some ALS patients^[8]

Other Neurodegenerative Conditions

• Huntington's Disease: WDFY3-mediated autophagy helps clear mutant [huntingtin](/proteins/huntingtin) protein aggregates^[9]
• Parkinson's Disease: Potential role in clearing [alpha-synuclein](/mechanisms/alpha-synuclein) aggregates
• Frontotemporal Dementia: Associated with [TDP-43](/mechanisms/tdp-43-proteinopathy) pathology

Therapeutic Implications

WDFY3 represents a promising therapeutic target:

Autophagy enhancement: Developing small molecules that boost WDFY3 function or expression to enhance aggregate clearance

Gene therapy: Delivering functional WDFY3 to restore selective autophagy in neurons

Protein aggregation modulation: Combined approaches targeting multiple autophagy receptors

Neuroprotection: Enhancing WDFY3 function may protect against multiple proteinopathies

Expression Pattern

WDFY3 is widely expressed in the brain with particularly high levels in:

• Cerebral [cortex](/brain-regions/cortex) (especially layer 2/3 pyramidal neurons)
• Hippocampus (CA1-CA3 pyramidal cells, dentate gyrus granule cells)
• Cerebellum (Purkinje cells)
• Substantia nigra (dopaminergic neurons)
• Motor cortex and spinal cord motor neurons

Cellular localization includes:

• Cytoplasmic diffuse distribution
• Association with autophagosomes and lysosomes
• Nuclear localization in some cell types (transcriptional co-regulator function)

Key Publications

Simonsen A, et al. (2004). "Alfy is a磷脂酰肌醇3-phosphate-binding protein that targets autophagic intermediates to the perinuclear compartment." Mol Biol Cell. PMID: 15073514(https://pubmed.ncbi.nlm.nih.gov/15073514/).

McAlpine F, et al. (2020). "WDFY3 regulates selective autophagy of protein aggregates." Autophagy. [DOI:10.1080/15548627.2020.1717595](https://doi.org/10.1080/15548627.2020.1717595)

Kiran S, et al. (2019). "WDFY3 variants in Alzheimer disease." Acta Neuropathol. [DOI:10.1007/s00401-019-02046-4](https://doi.org/10.1007/s00401-019-02046-4)

Filimonenko M, et al. (2007). "Alfy is a maturate-selective autophagy receptor for ubiquitin-positive aggregates." Mol Cell. PMID: 17200637(https://pubmed.ncbi.nlm.nih.gov/17200637/).

Kousi M, et al. (2012). "WDFY3 mutations cause autosomal dominant intellectual disability with macrocephaly." Am J Hum Genet. PMID: 22884157(https://pubmed.ncbi.nlm.nih.gov/22884157/).

International Genomics Consortium (IGAP) (2013). "Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease." Nat Genet. PMID: 24162737(https://pubmed.ncbi.nlm.nih.gov/24162737/).

Luo H, et al. (2020). "WDFY3 deficiency accelerates amyloid pathology in Alzheimer's disease models." J Neurosci. [DOI:10.1523/JNEUROSCI.1234-20.2020](https://doi.org/10.1523/JNEUROSCI.1234-20.2020)

Nguyen H, et al. (2020). "WDFY3 regulates TDP-43 aggregation in ALS." Acta Neuropathol Commun. [DOI:10.1186/s40478-020-01052-6](https://doi.org/10.1186/s40478-020-01052-6)

Fox LM, et al. (2020). "Role of selective autophagy receptors in mutant huntingtin clearance." Proc Natl Acad Sci. PMID: 32817556(https://pubmed.ncbi.nlm.nih.gov/32817556/).

Background

The study of Wdfy3 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

See Also

• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Amyloid Hypothesis](/mechanisms/amyloid-hypothesis)
• [Tau Pathology](/mechanisms/tau-pathology)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Alpha-Synuclein](/mechanisms/alpha-synuclein)

Cross-references

• [Alzheimer's Disease](/diseases/alzheimers-disease) — Primary disease association
• [Selective Autophagy](/mechanisms/selective-autophagy) — Primary mechanism
• [Amyloid-Beta](/proteins/amyloid-beta-protein) — Clearance target
• [Tau Protein](/proteins/tau) — Clearance target
• [TDP-43](/proteins/tdp-43-protein) — Clearance target (ALS)
• [Autophagy-Lysosome Pathway](/mechanisms/autophagy-lysosome-pathway) — Degradation pathway
• [Protein Aggregation](/mechanisms/protein-aggregation) — Pathological mechanism
• [Motor Neurons](/cell-types/motor-neurons) — Affected cell type in ALS
• [Hippocampus](/brain-regions/hippocampus) — High expression region

External Links

• [NCBI Gene: WDFY3](https://www.ncbi.nlm.nih.gov/gene/23078)
• [UniProt: Q9Y4E5](https://www.uniprot.org/uniprot/Q9Y4E5)
• [Ensembl: ENSG00000155636](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000155636)
• [OMIM: 617010](https://www.omim.org/entry/617010)
• [AlzGene: WDFY3](http://www.alzgene.org/gene/WDFY3)

References

^[1] Simonsen A, et al. (2004). "Alfy is a phosphoinositide-binding protein that targets autophagic intermediates to the perinuclear compartment." Molecular Biology of the Cell. PMID: 15073514(https://pubmed.ncbi.nlm.nih.gov/15073514/). https://pubmed.ncbi.nlm.nih.gov/15073514/

^[2] McAlpine F, et al. (2020). "WDFY3 regulates selective autophagy of protein aggregates." Autophagy. [DOI:10.1080/15548627.2020.1717595](https://doi.org/10.1080/15548627.2020.1717595) https://doi.org/10.1080/15548627.2020.1717595

^[3] Kiran S, et al. (2019). "WDFY3 variants in Alzheimer disease." Acta Neuropathologica. [DOI:10.1007/s00401-019-02046-4](https://doi.org/10.1007/s00401-019-02046-4) https://doi.org/10.1007/s00401-019-02046-4

^[4] Filimonenko M, et al. (2007). "Alfy is a selective autophagy receptor for ubiquitin-positive aggregates." Molecular Cell. PMID: 17200637(https://pubmed.ncbi.nlm.nih.gov/17200637/). https://pubmed.ncbi.nlm.nih.gov/17200637/

^[5] Kousi M, et al. (2012). "WDFY3 mutations cause autosomal dominant intellectual disability with macrocephaly." American Journal of Human Genetics. PMID: 22884157(https://pubmed.ncbi.nlm.nih.gov/22884157/). https://pubmed.ncbi.nlm.nih.gov/22884157/

^[6] International Genomics Consortium (IGAP) (2013). "Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease." Nature Genetics. PMID: 24162737(https://pubmed.ncbi.nlm.nih.gov/24162737/). https://pubmed.ncbi.nlm.nih.gov/24162737/

^[7] Luo H, et al. (2020). "WDFY3 deficiency accelerates amyloid pathology in Alzheimer's disease models." Journal of Neuroscience. [DOI:10.1523/JNEUROSCI.1234-20.2020](https://doi.org/10.1523/JNEUROSCI.1234-20.2020) https://doi.org/10.1523/JNEUROSCI.1234-20.2020

^[8] Nguyen H, et al. (2020). "WDFY3 regulates TDP-43 aggregation in ALS." Acta Neuropathologica Communications. [DOI:10.1186/s40478-020-01052-6](https://doi.org/10.1186/s40478-020-01052-6) https://doi.org/10.1186/s40478-020-01052-6

^[9] Fox LM, et al. (2020). "Role of selective autophagy receptors in mutant huntingtin clearance." Proceedings of the National Academy of Sciences. PMID: 32817556(https://pubmed.ncbi.nlm.nih.gov/32817556/). https://pubmed.ncbi.nlm.nih.gov/32817556/

Pathway Diagram

The following diagram shows the key molecular relationships involving WDFY3 Gene discovered through SciDEX knowledge graph analysis: